DI
The startup has developed a pocket-sized electronic inhalation device that delivers precision medications such as rapid-acting insulin and antivirals, replacing traditional injection methods. Its patent-pending customizable core technology enables pharmaceutical companies to reformulate expiring drugs, extending their patent protection through drug-device co-development.
Updated 18 months ago
Funding
$290K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
IA
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup has developed a pocket-sized electronic inhalation device that delivers precision medications such as rapid-acting insulin and antivirals, replacing traditional injection methods. Its patent-pending customizable core technology enables pharmaceutical companies to reformulate expiring drugs, extending their patent protection through drug-device co-development.